Literature DB >> 18251511

Fjord-region benzo[g]chrysene-11,12-dihydrodiol and benzo[c]phenanthrene-3,4-dihydrodiol as substrates for rat liver dihydrodiol dehydrogenase (AKR1C9): structural basis for stereochemical preference.

Carol A Shultz1, Nisha T Palackal, Dipti Mangal, Ronald G Harvey, Ian A Blair, Trevor M Penning.   

Abstract

This study demonstrates that benzo[g]chrysene-11,12-dihydrodiol (B[g]C-11,12-dihydrodiol) derived from the fjord-region parent hydrocarbon B[g]C is oxidized by rat AKR1C9 with a k c a t/ K m 100 times greater than that observed with the commonly studied bay-region benzo[ a]pyrene-7,8-dihydrodiol (B[a]P-7,8-dihydrodiol). Conversely, despite its strikingly similar structure to B[ g]C-11,12-dihydrodiol, benzo[ c]phenanthrene-3,4-dihydrodiol (B[ c]Ph-3,4-dihydrodiol) is consumed by AKR1C9 at sluggish rates comparable to those observed with B[ a]P-7,8-dihydrodiol. CD spectroscopy revealed that only the (+)-B[ g]C-11,12-dihydrodiol stereoisomer was oxidized, while AKR1C9 oxidized both stereoisomers of B[a]P-7,8-dihydrodiol and B[ c]Ph-3,4-dihydrodiol. The (+)- S, S- and (-)- R, R-stereoisomers of B[g]C-11,12-dihydrodiol were purified by chiral RP-HPLC. The 11 S,12 S-stereoisomer was oxidized at the same rate as the racemate. The 11 R,12 R-stereoisomer did not act as an inhibitor to AKR1C9, indicating that the (-)- R, R-stereoisomer was excluded from the active site. To understand the basis of stereochemical preference, we screened alanine-scanning mutants of active site residues of AKR1C9. These studies revealed that in comparison to the wild type, F129A, W227A, and Y310A enabled the oxidation of both the B[g]C-11 S,12 S-dihydrodiol and the B[g]C-11 R,12 R-dihydrodiol. Molecular modeling revealed that unlike B[a]P-7,8-dihydrodiol and B[ c]Ph-3,4-dihydrodiol, B[g]C-11,12-dihydrodiol enantiomers are significantly bent out of plane. As a consequence, the (-)- R, R-stereoisomer was prevented from binding to the active site because of unfavorable interactions with F129, W227, or Y310. Additionally, LC/MS validated that the product of the reaction of B[g]C-11,12-dihydrodiol oxidation catalyzed by AKR1C9 was B[g]C-11,12-dione, which was trapped in vitro with the nucleophile 2-mercaptoethanol. The similarity between rates of trans-dihydrodiol oxidation by the rat and human liver specific AKRs (AKR1C9 and AKR1C4) implicate these enzymes in hepatocarcinogenesis in rats observed with the fjord-region PAH.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18251511      PMCID: PMC2440589          DOI: 10.1021/tx7003695

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  40 in total

1.  The arginine 276 anchor for NADP(H) dictates fluorescence kinetic transients in 3 alpha-hydroxysteroid dehydrogenase, a representative aldo-keto reductase.

Authors:  K Ratnam; H Ma; T M Penning
Journal:  Biochemistry       Date:  1999-06-15       Impact factor: 3.162

2.  Carcinogenicity of polycyclic aromatic hydrocarbons.

Authors:  Kurt Straif; Robert Baan; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi; Vincent Cogliano
Journal:  Lancet Oncol       Date:  2005-12       Impact factor: 41.316

3.  Formation of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dGuo) by PAH o-quinones: involvement of reactive oxygen species and copper(II)/copper(I) redox cycling.

Authors:  Jong-Heum Park; Sridhar Gopishetty; Lawrence M Szewczuk; Andrea B Troxel; Ronald G Harvey; Trevor M Penning
Journal:  Chem Res Toxicol       Date:  2005-06       Impact factor: 3.739

4.  Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.

Authors:  Narayanan Balu; William T Padgett; Garret B Nelson; Guy R Lambert; Jeffrey A Ross; Stephen Nesnow
Journal:  Anal Biochem       Date:  2006-06-05       Impact factor: 3.365

5.  Competing roles of aldo-keto reductase 1A1 and cytochrome P4501B1 in benzo[a]pyrene-7,8-diol activation in human bronchoalveolar H358 cells: role of AKRs in P4501B1 induction.

Authors:  Hao Jiang; Daljit K Vudathala; Ian A Blair; Trevor M Penning
Journal:  Chem Res Toxicol       Date:  2006-01       Impact factor: 3.739

Review 6.  Dihydrodiol dehydrogenases and polycyclic aromatic hydrocarbon activation: generation of reactive and redox active o-quinones.

Authors:  T M Penning; M E Burczynski; C F Hung; K D McCoull; N T Palackal; L S Tsuruda
Journal:  Chem Res Toxicol       Date:  1999-01       Impact factor: 3.739

7.  Polycyclic aromatic hydrocarbon (PAH) o-quinones produced by the aldo-keto-reductases (AKRs) generate abasic sites, oxidized pyrimidines, and 8-oxo-dGuo via reactive oxygen species.

Authors:  Jong-Heum Park; Andrea B Troxel; Ronald G Harvey; Trevor M Penning
Journal:  Chem Res Toxicol       Date:  2006-05       Impact factor: 3.739

8.  Molecular docking simulations of steroid substrates into human cytosolic hydroxysteroid dehydrogenases (AKR1C1 and AKR1C2): insights into positional and stereochemical preferences.

Authors:  Yi Jin; Trevor M Penning
Journal:  Steroids       Date:  2006-02-07       Impact factor: 2.668

9.  Role of cytochrome p4501 family members in the metabolic activation of polycyclic aromatic hydrocarbons in mouse epidermis.

Authors:  Heather E Kleiner; Suryanarayana V Vulimiri; William B Hatten; Melissa J Reed; Daniel W Nebert; Colin R Jefcoate; John DiGiovanni
Journal:  Chem Res Toxicol       Date:  2004-12       Impact factor: 3.739

10.  Dibenzanthracenes and benzochrysenes elicit both genotoxic and nongenotoxic events in rat liver 'stem-like' cells.

Authors:  L Svihálková-Sindlerová; M Machala; K Pencíková; S Marvanová; J Neca; J Topinka; O Sevastyanova; A Kozubík; J Vondrácek
Journal:  Toxicology       Date:  2007-01-10       Impact factor: 4.221

View more
  1 in total

1.  The Role of Human Aldo-Keto Reductases in the Metabolic Activation and Detoxication of Polycyclic Aromatic Hydrocarbons: Interconversion of PAH Catechols and PAH o-Quinones.

Authors:  Li Zhang; Yi Jin; Meng Huang; Trevor M Penning
Journal:  Front Pharmacol       Date:  2012-11-16       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.